Routine blood test could spot silent liver disease
NCT ID NCT05880173
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether a common blood test, called FIB4, can help find people with advanced liver fibrosis (serious liver scarring) who don't know they have it. About 500 adults aged 18-70 with a high FIB4 result will get a more detailed liver check, including a special ultrasound and possibly a biopsy. The goal is to see if this screening approach works well enough to become a standard early detection tool.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
FIB4 blood test and FibroScan
What this could lead to
If successful, this could lead to a simple, routine blood test to catch serious liver scarring early in people who don't know they have it.
What could go wrong
This is an early screening study, not a treatment trial. The blood test may produce false positives or miss some cases, and the results need further validation before widespread use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCREENING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Hospitalier de Lens
RECRUITINGLens, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Chu Angers
NOT_YET_RECRUITINGAngers, 49000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Chu Bordeaux
NOT_YET_RECRUITINGAngers, 49000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Chu Grenoble Alpes
RECRUITINGGrenoble, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Chu Nancy
RECRUITINGNancy, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hopital Saint Joseph
NOT_YET_RECRUITINGMarseille, France
Contact Phone: •••-•••-•••• Email: •••••@•••••